26698023	Adenosine triphosphate	Perl A	Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.	Nature reviews. Rheumatology	2016	31
27013493	Adenosine triphosphate	Biniecka M	Dysregulated bioenergetics: a key regulator of joint inflammation.	Annals of the rheumatic diseases	2016	12
21239502	Tartaric acid	Shakibaei M	Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells.	The Journal of biological chemistry	2011	35
22868927	Serotonin	Boilard E	Platelets: active players in the pathogenesis of arthritis and SLE.	Nature reviews. Rheumatology	2012	34
17599072	Calcium	Foell D	Mechanisms of disease: a 'DAMP' view of inflammatory arthritis.	Nature clinical practice. Rheumatology	2007	80
19877063	Calcium	Saag KG	Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.	Arthritis and rheumatism	2009	48
26246395	Oxygen	Rainsford KD	Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.	Inflammopharmacology	2015	23
27225300	Oxygen	Fearon U	Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis.	Nature reviews. Rheumatology	2016	11
23687260	Folic acid	Yoo DH	A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study.	Annals of the rheumatic diseases	2013	70
25070946	L-Phenylalanine	Okada Y	Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations.	Human molecular genetics	2014	22
25804398	L-Phenylalanine	Nemethova M	Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in Italy.	European journal of human genetics 	2016	11
16447241	Methotrexate	Wolfe F	Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.	Arthritis and rheumatism	2006	64
16705046	Methotrexate	Hyrich KL	Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.	Rheumatology	2006	112
17469100	Methotrexate	Wolfe F	The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.	Arthritis and rheumatism	2007	59
17632266	Methotrexate	Ramos-Casals M	Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.	Medicine	2007	77
24168956	Methotrexate	Smolen JS	Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial.	Lancet	2014	51
25367713	Methotrexate	Emery P	Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period.	Annals of the rheumatic diseases	2015	28
25660991	Methotrexate	Haschka J	Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.	Annals of the rheumatic diseases	2016	12
27307501	Methotrexate	Cappelli LC	Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.	Annals of the rheumatic diseases	2017	17
25155581	Progesterone	Hughes GC	Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.	Nature reviews. Rheumatology	2014	22
16760194	L-Tyrosine	Lee YH	The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis.	Rheumatology	2007	65
23719833	L-Tyrosine	Graham GG	The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.	Inflammopharmacology	2013	37
19185000	Pyruvic acid	Lleo A	Apotopes and the biliary specificity of primary biliary cirrhosis.	Hepatology	2009	61
27457513	Aspirin	Andreoli L	EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.	Annals of the rheumatic diseases	2017	10
22293756	L-Cysteine	Harris HE	HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.	Nature reviews. Rheumatology	2012	143
16697362	24,25-Dihydroxyvitamin D	Speeckaert M	Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism.	Clinica chimica acta; international journal of clinical chemistry	2006	106
27221134	Sirolimus	Elkaim E	Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.	The Journal of allergy and clinical immunology	2016	18
24977961	Auranofin	Liu N	Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth.	Oncotarget	2014	34
15306601	Lamivudine	Esteve M	Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.	Gut	2004	73
